HLA-DRB1 and myeloid sarcoma: These findings suggest that EBV is inefficiently immune controlled in the context of HLA-DRB1*1501 and that the resulting increased numbers of EBV infected B cells might stimulate in turn myelin antigen specific autoreactive T cell responses to cause MS.